ImVacS brings together international vaccine leaders to discuss challenges and current breakthroughs in the world of vaccines. The four vaccine-focused meetings address innovating strategies to meet current health threats, changing technology for vaccine manufacture, top challenges faced during pre-clinical development, and progress underway for adjuvants and novel delivery systems. Altogether, ImVacS provides a snapshot of where vaccine development stands today in a collegial atmosphere that fosters information exchange, networking and establishing collaborations. We hope you will join the discussion aimed to advance vaccine science.

Keynotes:

David Cho, Ph.D., M.P.H., Senior Scientist for Emerging and Pandemic Threat Preparedness, Office of the Director, Center for Biologics Evaluation and Research (CBER), FDA

Norman Baylor, Ph.D., Director, Office of Vaccines Research and Review (OVRR), Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, FDA

Jay Berzofsky, M.D., Ph.D., Chief, Vaccine Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health

George Siber, Ph.D., Director, Selecta Biosciences, and Executive Chairman, Genocea Biosciences

Monday, August 16 Pre-Conference Short Courses:

SC1 Vaccines Business Opportunities: Collaborations, Mergers And Acquisitions

SC2 Single-Use Systems (Disposables) For Vaccine Manufacture

Event Highlights:

• 4 Conferences, ONE Location!
• Over 60 Presentations
• Panel Discussions
• Exhibit & Poster Viewing